Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

This prospective study was to assess the efficacy of nonbismuth containing quadruple therapy as first-line H. pylori treatment and to determine the clinical factors influencing patient outcome. We enrolled 200 H. pylori-infected naïve patients. They were prescribed either a 7-day nonbismuth containi...

Full description

Bibliographic Details
Main Authors:	Wei-Chen Tai, Chih-Ming Liang, Chen-Hsiang Lee, Chien-Hua Chiu, Ming-Luen Hu, Lung-Sheng Lu, Yuan-Hung Kuo, Chung-Mou Kuo, Yi-Hao Yen, Chung-Huang Kuo, Shue-Shian Chiou, Keng-Liang Wu, Yi-Chun Chiu, Tsung-Hui Hu, Seng-Kee Chuah
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/623732

Similar Items

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
by: Tai WC, et al.
Published: (2019-09-01)

A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]
by: Tai WC, et al.
Published: (2019-09-01)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
by: Wei-Chen Tai, et al.
Published: (2013-01-01)

The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication.
by: Wei-Chen Tai, et al.
Published: (2014-01-01)

Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice
by: Chih-Ming Liang, et al.
Published: (2014-10-01)

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
by: Sung-Shuo Kao, et al.
Published: (2012-01-01)

First-line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan
by: Cheng-En Tsai, et al.
Published: (2016-08-01)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
by: Chih-Ming Liang, et al.
Published: (2017-01-01)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
by: Huang HT, et al.
Published: (2018-10-01)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
by: Seng-Kee Chuah, et al.
Published: (2014-01-01)

Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020-09-01)

Eradication of Helicobacter pylori infection
by: Tzung-Shiun Wu, et al.
Published: (2014-04-01)

Helicobacter Pylori Eradication in Renal Recipient: Triple or Quadruple Therapy?
by: Seyed Mousal Reza Hosseini, et al.
Published: (2014-04-01)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
by: Hung KT, et al.
Published: (2021-03-01)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
by: Chung-Mou Kuo, et al.
Published: (2019-06-01)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
by: Gisbert JP, et al.
Published: (2012-03-01)

Two-day, high dosage, quadruple therapy for eradication of Helicobacter pylori
by: Zheng, Zhi-Xian, et al.

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
by: Guang-Hong Jheng, et al.
Published: (2015-01-01)

The incidence and clinical associated factors of interval colorectal cancers in Southern Taiwan
by: Cheng-En Tsai, et al.
Published: (2018-03-01)

Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection
by: Mohsen Razavizadeh, et al.
Published: (2020-01-01)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01)

The effect of dietary carbohydrate on gastroesophageal reflux disease
by: Keng-Liang Wu, et al.
Published: (2018-11-01)

The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen
by: Joonhwan Kim, et al.
Published: (2018-04-01)

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Qian Hu, et al.
Published: (2020-02-01)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
by: Ming-Cheh Chen, et al.
Published: (2014-01-01)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01)

Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy
by: Evgenii I. Olekhnovich, et al.
Published: (2019-08-01)

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
by: F. Zhang, et al.
Published: (2016-01-01)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
by: Liang Chih-Ming, et al.
Published: (2012-03-01)

Ebola could be eradicated through voluntary vaccination
by: Andrew Brettin, et al.
Published: (2018-01-01)

Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage
by: Chiu Yi-Chun, et al.
Published: (2012-06-01)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
by: Fahad Alsohaibani, et al.
Published: (2020-01-01)

Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication of Helicobacter pylori
by: Raymond Lahaie, et al.
Published: (2001-01-01)

Ninety-seven Eclipsing Quadruple Star Candidates Discovered in TESS Full-frame Images
by: Kostov, Veselin B, et al.
Published: (2022)

Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for <i>Helicobacter pylori</i> eradication in dyspepsia
by: Agah Shahram, et al.
Published: (2009-01-01)

Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
by: Antonietta G. Gravina, et al.
Published: (2021-04-01)

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota
by: S. Prast-Nielsen, et al.
Published: (2019-11-01)

Outcome of Holiday and Nonholiday Admission Patients with Acute Peptic Ulcer Bleeding: A Real-World Report from Southern Taiwan
by: Tsung-Chin Wu, et al.
Published: (2014-01-01)

A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience
by: Chih-Ming Liang, et al.
Published: (2019-04-01)

Associated factors in Streptococcus bovis bacteremia and colorectal cancer
by: Cheng-En Tsai, et al.
Published: (2016-04-01)

Cannot write session to /tmp/vufind_sessions/sess_jvo94h6a7sb42lca5jl3vno9f3